Showing results (151-160 of 190) with videos related to
Sort By:
Pageof 19
Cell Metabolism|December 15, 2023
ChREBP is activated by reductive stress and mediates GCKR-associated metabolic traitsCharandeep Singh, Byungchang Jin, Nirajan Shrestha, et al.Research Connections|April 30, 2026
Feasibility and acceptability of an electronic decision aid for genetic testing in ovarian and pancreatic cancer patientsDanielle A Lynch, Sarah Wiser, Devanshi Patel, et al.Cancer Research|October 15, 2009
Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancerLei Xu, Dan G Duda, Emmanuelle di Tomaso, et al.The Oncologist|July 30, 2010
A safety and survival analysis of neoadjuvant bevacizumab with standard chemoradiation in a phase I/II study compared with standard chemoradiation in locally advanced rectal cancerChristopher G Willett, Dan G Duda, Marek Ancukiewicz, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2019
Microscopic Colitis Is Characterized by Intestinal DysbiosisDavid M Morgan, Yueming Cao, Kaia Miller, et al.Plos One|May 14, 2013
AAV-mediated gene therapy for choroideremia: preclinical studies in personalized modelsVidyullatha Vasireddy, Jason A Mills, Rajashekhar Gaddameedi, et al.Cancer Science|April 22, 2008
Sonic hedgehog derived from human pancreatic cancer cells augments angiogenic function of endothelial progenitor cellsMadoka Yamazaki, Kazumasa Nakamura, Yusuke Mizukami, et al.Cancer Biology & Therapy|December 7, 2007
Mechanisms of Cables 1 gene inactivation in human ovarian cancer developmentHideo Sakamoto, Anne M Friel, Antony W Wood, et al.Cell Host & Microbe|August 20, 2013
Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironmentAleksandar D Kostic, Eunyoung Chun, Lauren Robertson, et al.The Lancet. Oncology|January 8, 2008
Gastroenteropancreatic neuroendocrine tumoursIrvin M Modlin, Kjell Oberg, Daniel C Chung, et al.Pageof 19